☆ 4.6 Letter

In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

BLOOD ADVANCES (2021)

Get Full Text
Add to Collection

Journal

BLOOD ADVANCES
Volume 5, Issue 23, Pages 5057-5059

Publisher

ELSEVIER
DOI: 10.1182/bloodadvances.2021004983

Keywords

-

Categories

Hematology

Funding

  1. Biostatistics Shared Resource, Knight Cancer Institute (National Institutes of Health National Cancer Institute) [P30CA069533]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.